BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 16968800)

  • 1. Review: The role of insulin resistance in nonalcoholic fatty liver disease.
    Utzschneider KM; Kahn SE
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4753-61. PubMed ID: 16968800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diets and nonalcoholic fatty liver disease: the good and the bad.
    Asrih M; Jornayvaz FR
    Clin Nutr; 2014 Apr; 33(2):186-90. PubMed ID: 24262589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: the potential role of nutritional management.
    Leclercq IA; Horsmans Y
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):766-73. PubMed ID: 18827582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
    Lê KA; Bortolotti M
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in children.
    Alisi A; Locatelli M; Nobili V
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):397-402. PubMed ID: 20531177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
    Tilg H; Moschen A
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and NAFLD: the role of bacteria and microbiota.
    Duseja A; Chawla YK
    Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
    Scorletti E; Byrne CD
    Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
    Qureshi K; Abrams GA
    World J Gastroenterol; 2007 Jul; 13(26):3540-53. PubMed ID: 17659704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation.
    Roth CL; Elfers CT; Figlewicz DP; Melhorn SJ; Morton GJ; Hoofnagle A; Yeh MM; Nelson JE; Kowdley KV
    Hepatology; 2012 Apr; 55(4):1103-11. PubMed ID: 21994008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and lipids.
    Wierzbicki AS; Oben J
    Curr Opin Lipidol; 2012 Aug; 23(4):345-52. PubMed ID: 22617751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
    Orlik B; Handzlik G; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.